Galileo CDS is an innovative company founded in 2015 that is revolutionizing the field of diagnostic radiology. By leveraging Machine Learning and their extensive expertise, Galileo aims to enhance radiology tools significantly, thereby alleviating the workload of radiologists.
Operating at the intersection of AI, Big Data, Education, Health Care, Robotics, and Machine Learning, the company is well-positioned in the rapidly growing sector of technological health solutions. With its headquarters in the United States, Galileo is ideally situated to capitalize on the burgeoning market opportunities in health technology.
The company's last recorded investment was a $113.33K Seed Round on 08 December 2020. Given its strategic use of cutting-edge technology and significant impact potential, Galileo CDS presents a compelling case for further investment in the evolving health care landscape.